Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$6.4 - $14.73 $1,792 - $4,124
-280 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$25.17 - $36.85 $1,862 - $2,726
-74 Reduced 20.9%
280 $8,000
Q3 2021

Nov 12, 2021

BUY
$30.02 - $39.87 $270 - $358
9 Added 2.61%
354 $12,000
Q2 2021

Aug 17, 2021

BUY
$32.22 - $44.59 $11,115 - $15,383
345 New
345 $14,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.